Free Access
Issue
Med Sci (Paris)
Volume 21, Number 1, Janvier 2005
Page(s) 89 - 94
Section Dossier technique
DOI https://doi.org/10.1051/medsci/200521189
Published online 15 January 2005
  1. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334 : 693–9. [Google Scholar]
  2. Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced stage hepatocellular carcinoma. Hepatology 1995; 21 : 403–7. [Google Scholar]
  3. Belghiti J, Panis Y, Farges O, et al. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991; 214 : 114–7. [Google Scholar]
  4. Hemming AW, Cattral MS, Reed AI, et al. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001; 223 : 652–9. [Google Scholar]
  5. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure : definitions and causes. Semin Liver Dis 1986; 6 : 97–106. [Google Scholar]
  6. Gow PJ, Pillay D, Mutimer D. Solid organ transplantation in patients with HIV infection. Transplantation 2001; 72 : 177–81. [Google Scholar]
  7. Prachalias AA, Pozniak A, Taylor C, et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001; 72 : 1684–8. [Google Scholar]
  8. Trotter JF, Talamantes M, McClure M, et al. Right hepatic lobe donation for living donor liver transplantation : impact on donor quality of life. Liver Transpl 2001; 7 : 485–93. [Google Scholar]
  9. Toso C, Ris F, Mentha G, et al. Potential impact of in situ liver splitting on the number of available grafts. Transplantation 2002; 74 : 222–6. [Google Scholar]
  10. O’grady JG, Burroughs A, Hardy P, et al. Tacrolimus versus microemulsified ciclosporin in liver transplantation : the TMC randomised controlled trial. Lancet 2002; 360 : 1119–25. [Google Scholar]
  11. Boillot O, Viale JP, Gratadour P, et al. Reversal of early acute rejection with increased doses of tacrolimus in liver transplantation : a pilot study. Transplantation 1998; 66 : 1182–5. [Google Scholar]
  12. Wiesner RH, Demetris AJ, Belle SH, et al. Acute hepatic allograft rejection : incidence, risk factors and impact on outcome. Hepatology 1998; 28 : 638–45. [Google Scholar]
  13. Shirwan H. Chronic allograft rejection. Transplantation 1999; 68 : 715–26. [Google Scholar]
  14. Schlitt HJ, Barkmann A, Boker KHW, et al. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver transplant patients with renal dysfunction : a randomised controlled study. Lancet 2001; 357 : 587–91. [Google Scholar]
  15. Denys AL, Qanadli SD, Durand F, et al. Feasibility and effectiveness of using coronary stents in the treatment of hepatic artery stenoses after orthotopic liver transplantation : preliminary report. Am J Roentgenol 2002; 178 : 1175–9. [Google Scholar]
  16. Sawyer SG, Punch JD. Incidence and management of biliary complications after 291 following the introduction of transcystic stenting. Transplantation 1998; 66 : 1201–7. [Google Scholar]
  17. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation : increase in recent years. J Hepatol 2000; 32 : 673–84. [Google Scholar]
  18. Wali M, Harrison RF, Gow PJ, Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002; 51 : 248–52. [Google Scholar]
  19. Lavezzo B, Franchello A, Smedile A, et al. Treatment of recurrent hepatitis C in liver transplants : efficacy of a six versus twelve month course of interferon alfa 2b with ribavirin. J Hepatol 2002; 37 : 247–52. [Google Scholar]
  20. Lo CM, Fan ST, Liu CL, et al. Prophylaxis and treatment of recurrent hepatitis B virus infection after liver transplantation. Transplantation 2003; 75 : S41–4. [Google Scholar]
  21. Fontana RJ, Hann HW, Wright T, et al. A multicenter study of lamivudine treatment of 33 patients with hepatitis B after liver transplantation. Liver Transpl 2001; 7 : 504–10. [Google Scholar]
  22. Gerhardt TC, Goldstein RM, Urschel HC, et al. Alcohol use following liver transplantation for alcoholic cirrhosis. Transplantation 1996; 62 : 1060–3. [Google Scholar]
  23. Selzner N, Durand F, Bernuau J, et al. Conversion from cyclosporine to FK506 in adult liver transplant recipients : a combined north american and european experience. Transplantation 2001; 72 : 1061–5. [Google Scholar]
  24. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349 : 931–40. [Google Scholar]
  25. Dew MA, Switzer GE, Goycoolea JM, et al. Does transplantation produce quality of life benefits ? Transplantation 1997; 64 : 1261–73. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.